MENU CLOSE

News

Gateway to the Brain

Your gateway to company updates, events, and our latest research milestones

scroll

Our Latest News

  • News
  • Events

Noselab Successfully Hosts First Brain-Nose Symposium

Noselab’s inaugural Brain-Nose Symposium drew leading scientists and clinicians from around the world to Munich. With outstanding presentations, lively exchanges, and strong international participation, the event highlighted the growing relevance of the Brain-Nose Interface to develop more effective diagnostics and better therapies for brain disorders.
Read more
  • News
  • Events

Noselab Showcases Non-Invasive Window to the Brain at BIO-Europe 2025 in Vienna

Noselab GmbH joined the acclaimed BIO-Europe 2025 partnering event, introducing our latest innovation in healthcare and medical breakthroughs based on our revolutionary diagnostic platform. Marion San Nicoló, MD and Dr. Peter Fruhstorfer engaged with fellow experts, sharing knowledge about the brain-nose interface to advance disease understanding, diagnosis and treatment.
Read more
  • Events

Welcome to the Future of the Brain-Nose Interface!

We’re bringing together scientists, clinicians, and innovators from around the world for a one-day deep dive into one of the most exciting emerging topics in neuroscience and medicine: the Brain-Nose Interface (BNI). We are exploring the direct link between the nose and the brain – with exiting implication for diagnostics, therapeutics and interdisciplinary science.
Read more
  • News

Noselab GmbH Showcases Revolutionary Diagnostic Platform for Neurodegenerative Diseases at 2024 AD/PD Conference in Lisbon

Following Noselab´s successful presentations at CTAD 2023 and the BioCapital Europe Investor Conference, we are all set to showcase our innovative diagnostic platform at the highly anticipated 2024 AD/PD Conference in Lisbon, Portugal. Learn more about Noselab’s pioneering work at AD/PD 2024, where we unveil our groundbreaking diagnostic platform!
Read more
  • Events

Noselab Goes AD/PD™ 2024

Be part of our journey as we join the esteemed AD/PD™ 2024 International Conference on Alzheimer's and Parkinson's Diseases! Visit us in Lisbon from March 5th to 9th, 2024. At our booth (#19) we will present our revolutionary diagnostic platform approach based on nasal-derived CSF (nCSF) and related research milestones.
Read more